A Phase III, Multicenter, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Intravenous Peramivir in Subjects With Uncomplicated Influenza.
Phase of Trial: Phase III
Latest Information Update: 13 Dec 2011
At a glance
- Drugs Peramivir (Primary)
- Indications Influenza A virus infections; Influenza B virus infections
- Focus Therapeutic Use
- 13 Dec 2011 Actual patients number (1) added as reported by ClinicalTrials.gov.
- 13 Dec 2011 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
- 13 Dec 2011 Planned end date changed from 1 Nov 2011 to 1 Nov 2010 as reported by ClinicalTrials.gov.